Anath Shalev
Affiliations: | Endocrinol-Reprod Physiol - AG | University of Wisconsin, Madison, Madison, WI |
Area:
Molecular Biology, Endocrinology Biology, NutritionGoogle:
"Anath Shalev"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xu G, Chen J, Lu B, et al. (2023) Verapamil prevents decline of IGF-1 in subjects with T1D and promotes beta-cell IGF-1 signaling. Diabetes |
| Lu B, Chen J, Xu G, et al. (2022) Alpha cell TXNIP deletion improves diabetes-associated hyperglycemia and hyperglucagonemia. Endocrinology |
| Xu G, Chen J, Jo SH, et al. (2022) Deletion of Gdf15 reduces ER stress-induced beta cell apoptosis and diabetes. Endocrinology |
| Xu G, Grimes TD, Grayson TB, et al. (2022) Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes. Nature Communications. 13: 1159 |
| Thielen LA, Chen J, Jing G, et al. (2020) Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action. Cell Metabolism |
| Xu G, Jo S, Chen J, et al. (2020) 50-OR: Beta Cell GDF15 Contributes to Diabetic Stress-Induced Beta-Cell Loss Diabetes. 69 |
| Jo S, Xu G, Jing G, et al. (2020) 2304-PUB: Increased Glucagon Expression in Diabetes: The Role of miR-320a Diabetes. 69 |
| Xu G, Thielen LA, Chen J, et al. (2019) Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss. American Journal of Physiology. Endocrinology and Metabolism |
| Ovalle F, Grimes T, Xu G, et al. (2018) Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nature Medicine |
| Thielen L, Shalev A. (2018) Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Current Opinion in Endocrinology, Diabetes and Obesity. 25: 75-80 |